A carregar...
When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?
The current use of chloroquine and/or hydroxychloroquine, a drug currently used to treat autoimmune rheumatic diseases, in treating severe acute respiratory syndrome caused by coronavirus 2 (SARSCoV-2) or COVID-19-infected patients with pneumonia is a matter of intense consideration. We wish to ente...
Na minha lista:
| Publicado no: | Mediterr J Rheumatol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219635/ https://ncbi.nlm.nih.gov/pubmed/32411941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.1.94 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|